Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot study of NMN in children born preterm
jRCTs031250189Recruiting
- Sponsor
- Grants-in-Aid for Scientific Research
- Start
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of nicotinamide mononucleotide in preterm birth complication and very low birth weight (VLBW), sponsored by Grants-in-Aid for Scientific Research. Primary endpoint: Safety evaluation. Started Jun 2025; status: recruiting.
02
Drugs
nicotinamide mononucleotide
03
Conditions
preterm birth complicationvery low birth weight (VLBW)
Beyond the preview
Go deeper on jRCTs031250189.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031250189.